Results 61 to 70 of about 21,275,692 (207)
Background The 9th edition of the lung cancer tumor‐node‐metastasis (TNM) staging introduced adjustments, including the reclassification of T1N1M0 patients from stage IIB to IIA. This update used data mostly from Asian populations.
Jingsheng Cai, Yun Li, Feng Yang
doaj +1 more source
Comparison of platinum and non-platinum based regimens in the treatment of small cell lung cancer
Small cell lung cancer, and lung cancer in general, remains one of the most impactful public health issues in the modern age due to its high morbidity and mortality.
Benyarko, Ato
core
The tertiary lymphoid structure (TLS) plays a crucial role in the tumor microenvironment, influencing tumor development and progression. As an emerging biomarker for predicting the prognosis and treatment response in cancer patients, TLS has received ...
Lung Cancer Collaboration Group of Tumor Pathology Committee of Chinese Anti-Cancer Association +1 more
doaj +1 more source
Chemotherapy of non-small cell lung cancer [PDF]
Discussion sur l'interet de l'utilisation d'anticancereux dans le traitement de l'epithelioma bronchopulmonaire non petite ...
openaire +2 more sources
Objective: Previous studies have indicated that EGFR exon 19 deletions in non-small cell lung cancer (NSCLC) are associated with better outcomes to tyrosine kinase inhibitors (TKIs) than the L858R mutation.
Chen, Li-Yang;Molina-Vila, Miguel A.;Ruan, Sheng-Yuan;Su, Kang-Yi;Liao, Wei-Yu;Yu, Kai-Lun;Ho, Chao-Chi;Shih, Jin-Yuan;Yu, Chong-Jen;Yang, James Chih-Hsin;Rosell, Rafael;Yang, Pan-Chyr +1 more
core +1 more source
Lung cancers are broadly classified into small cell lung cancer and non–small cell lung cancer, with non–small cell lung cancer one of the leading causes of cancer-associated deaths worldwide.
Chunwei Lu, Jun Ma, Dingfang Cai
doaj +1 more source
Maintenance therapies for non small cell lung cancer
Treatment of lung cancer had evolved during the last decade with the introduction of new chemotherapeutic regimens and targeted therapies. However, the maximum benefit reached after first line therapy is limited by the cumulative toxicity of platinum ...
Normand eBlais, Elie eKassouf
doaj +1 more source
Update in non small- cell lung cancer staging
Significant progress has been made with the introduction of the TNM-7 staging system for non-small cell lung cancer (NSCLC). Constituting the first major revision in 12 years, the seventh edition of NSCLC TNM (TNM-7) is based on the recommendations from ...
RA Salgado +5 more
doaj +1 more source
Infrequent Detection of Microsatellite Alterations in Serum DNA of Non-Small Cell Lung Cancer Patients [PDF]
Recent studies indicate that soluble tumor DNA and microsatellite alterations have been identified in the peripheral blood of small cell lung cancer patients.
町田, 恵美 +13 more
core
Vascular phenotype in angiogenic and non-angiogenic lung non-small cell carcinomas. [PDF]
We have previously described a group of non-small cell lung carcinomas without morphological evidence of neo-angiogenesis. In these tumours neoplastic cells fill up the alveoli and the only vessels present appear to belong to the trapped alveolar septa ...
Nicholson, Andrew G. +45 more
core +1 more source

